Beta Bionics, Inc.
BBNX· Nasdaq
BBNXBeta Bionics, Inc.
Filed Oct 28, 2025 · 10-Q · 28 days after period end · 0001193125-25-253538
| Metric | Q3 2025 | Q3 2024 |
|---|---|---|
| Revenue | $27.25M | $16.71M |
| Net Income | -$14.21M | -$9.74M |
| EPS Diluted | -$0.33 | -$1.46 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Beta Bionics, Inc. · CIK 1674632 · Engraved from SEC EDGAR
ended Sep 30, 2025 · filed Oct 28, 2025 · 28 d after period end
